These past several months have been extremely exciting for ReceptoPharm as we continue to grow and progress with our clinical trials.
I’d like to take this opportunity to help clarify our most recent press release from April 11th, which discusses ReceptoPharm’s newest patent surrounding autoimmune diseases. As we mentioned in the press release, the ReceptoPharm patent […]
|
||||
|
|
||||
